For those searching for a job at SUN think about this. Merck is one of the most profitable pharma companies in US. Why did they sell Ilumya to SUN? Just thinking....
Not big enough for a company who thinks big and expects big. Market is crowded and Ilumya does not offer any breakthrough differentiation. Biologic without data at a high price and limited access. Perfect for SUN.
